AstraZeneca Withdraws COVID-19 Vaccine Globally Amid Lower Demand
Source: @ricxxxkiddo (X)
AstraZeneca has announced the global withdrawal of its COVID-19 vaccine on Tuesday, May 7, citing a surplus of updated vaccines available worldwide amidst the ongoing pandemic.
The pharmaceutical company stated its intention to withdraw marketing authorizations for its vaccine, Vaxzevria, within Europe due to the emergence of multiple variant COVID-19 vaccines. This surplus of alternatives has led to a decreased demand for Vaxzevria, prompting AstraZeneca to cease its production and supply.
Recent media reports have highlighted AstraZeneca’s acknowledgment, in court documents, of side effects associated with the vaccine, including blood clots and low blood platelet counts.
The firm initiated the withdrawal process for the vaccine on March 5, with the decision officially taking effect on May 7, as reported by the Telegraph. This development comes as AstraZeneca diversifies its focus, venturing into respiratory syncytial virus vaccines and obesity drugs following a slowdown in COVID-19 medicine sales last year.
AstraZeneca has announced the global withdrawal of its COVID-19 vaccine on Tuesday, May 7, citing a surplus of updated vaccines available worldwide amidst the ongoing pandemic.
The pharmaceutical company stated its intention to withdraw marketing authorizations for its vaccine, Vaxzevria, within Europe due to the emergence of multiple variant COVID-19 vaccines. This surplus of alternatives has led to a decreased demand for Vaxzevria, prompting AstraZeneca to cease its production and supply.
Recent media reports have highlighted AstraZeneca’s acknowledgment, in court documents, of side effects associated with the vaccine, including blood clots and low blood platelet counts.
The firm initiated the withdrawal process for the vaccine on March 5, with the decision officially taking effect on May 7, as reported by the Telegraph. This development comes as AstraZeneca diversifies its focus, venturing into respiratory syncytial virus vaccines and obesity drugs following a slowdown in COVID-19 medicine sales last year.
Video :
